Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-01-06
1988-08-23
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514254, 5142332, A61K 31505, A61K 31535
Patent
active
047661267
ABSTRACT:
An agent for treatment and prevention of nephritis comprising at least one imidazoquinazoline compound represented by formula ##STR1## wherein R.sub.1 represents a dialkylamino group having 1 to 6 carbon atoms in each alkyl moiety, or an unsubstituted or substituted cyclic amino group; and R.sub.2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, or an alkoxy group having 1 to 6 carbon atoms, or a salt thereof as an active ingredient.
REFERENCES:
patent: 4596806 (1986-06-01), Ishikawa et al.
patent: 4610987 (1986-09-01), Ishikawa
Daiichi Seiyaku Co., Ltd.
Daus Donald G.
Rivers Diana G.
LandOfFree
Process for treatment of nephritis with imidazoquinazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for treatment of nephritis with imidazoquinazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treatment of nephritis with imidazoquinazolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-836049